About Asha Therapeutics
Asha Therapeutics is a company based in Tampa (United States) founded in 2021 by Bradlee Heckmann and Sam Shrivastava.. Asha Therapeutics has raised $1.38 million across 1 funding round. Asha Therapeutics offers products and services including PRISM Drug Design and ASHA-624.
- Headquarter Tampa, United States
- Founders Bradlee Heckmann, Sam Shrivastava
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Asha Therapeutics, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.38 M (USD)
in 1 rounds
-
Latest Funding Round
$1.38 M (USD), Seed
Jul 25, 2022
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Asha Therapeutics
Asha Therapeutics offers a comprehensive portfolio of products and services, including PRISM Drug Design and ASHA-624. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology for modeling target structures and designing new chemical molecules.
Disease-modifying treatment for Amyotrophic Lateral Sclerosis and related disorders.
Unlock access to complete
Unlock access to complete
Funding Insights of Asha Therapeutics
Asha Therapeutics has successfully raised a total of $1.38M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.38 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.4M
-
First Round
First Round
(25 Jul 2022)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Seed - Asha Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Asha Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Asha Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Asha Therapeutics Comparisons
Competitors of Asha Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Asha Therapeutics
When was Asha Therapeutics founded?
Asha Therapeutics was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is Asha Therapeutics located?
Asha Therapeutics is headquartered in Tampa, United States. It is registered at Tampa, Florida, United States.
Who is the current CEO of Asha Therapeutics?
Sam Shrivastava is the current CEO of Asha Therapeutics. They have also founded this company.
Is Asha Therapeutics a funded company?
Asha Therapeutics is a funded company, having raised a total of $1.38M across 1 funding round to date. The company's 1st funding round was a Seed of $1.38M, raised on Jul 25, 2022.
What does Asha Therapeutics do?
Asha Therapeutics was founded in 2021 and is headquartered in Tampa, United States. Therapeutics for neurodegenerative diseases, including Parkinsons Disease, Alzheimers Disease, Amyotrophic Lateral Sclerosis, stroke, and neuro-oncology, are developed. A pipeline of drug candidates such as ASHA-091, ASHA-624, and ASHA-044 is advanced through the PRISM platform, which incorporates proprietary algorithms and simulation programs to identify drug targets and predict reactions. Operations focus on biotech innovation in the pharmaceutical sector.
What products or services does Asha Therapeutics offer?
Asha Therapeutics offers PRISM Drug Design and ASHA-624.